IHC-P: Ready to use, suggested incubation period of 30 minutes at room temperature. Optimal dilutions/concentrations should be determined by the end user.
Antibody reacts with intracytoplasmic portion of the CD3 antigen on the T cells. It stains T cells in cortex as well as medulla of the thymus and lymphoid tissues. This antibody also labels T cell neoplasm, malignant histiocytes and in Hodgkin's disease.
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Synthetic peptide (Human) conjugated to BSA.
Protein A purified
For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
T3E, 186740, P09693, T3D, 916, CD3-GAMMA, 917, CD3GAMMA, TCRE, P20963, 186830, 186780, P04234, CD3ZETA, CD3H, CD3Q, CD3E, CD3, CD3-DELTA, TCRZ, 919, CD3Z, CD3G, 915, CD3-ZETA, 186790, T3G, CD3D, P07766, CD3DELTA, CD3 ZETA, CD3 GAMMA, CD3 DELTA
Type I membrane protein.
T cell activation through the antigen receptor (TCR) involves the cytoplasmic tails of the CD3 subunits CD3 gamma, CD3 delta, CD3 epsilon and CD3 zeta. These CD3 subunits are structurally related members of the immunoglobulins super family encoded by closely linked genes on human chromosome 11. The CD3 components have long cytoplasmic tails that associate with cytoplasmic signal transduction molecules. This association is mediated at least in part by a double tyrosine-based motif present in a single copy in the CD3 subunits. CD3 may play a role in TCR-induced growth arrest, cell survival and proliferation.